Target intelligence / Profile preview

Sorokinianin

Molecular classification
Sesterterpenoid, Phytotoxin, Secondary metabolite
01

Overview

Sorokinianin is a tricyclic sesterterpenoid phytotoxin produced by the fungus Bipolaris sorokiniana, a significant pathogen responsible for diseases such as spot blotch and common root rot in cereal crops like wheat and barley [4, 5, 8, 12]. In the agricultural context, the molecule acts as a virulence factor that suppresses plant immunity and inhibits seed germination, thereby facilitating fungal colonization [5, 14]. Molecular docking and experimental studies have revealed that Sorokinianin interacts with the G-protein alpha (Gα) and beta (Gβ) subunits of the host plant's heterotrimeric G-protein system, interfering with critical signaling pathways during infection [2, 14]. Beyond its role in plant pathology, recent pharmacological research has identified its potential anti-inflammatory properties in mammalian systems, specifically through its ability to inhibit the production of nitric oxide (NO) in lipopolysaccharide-stimulated macrophages [12]. Despite these biological activities, Sorokinianin is a small molecule metabolite and is not classified as a therapeutic protein, receptor, or enzyme target in human medicine.

Other names
(+)-Sorokinianin3-hydroxy-sorokinianin
02

Mechanism of action

Binds to and inhibits the function of heterotrimeric G-protein subunits (Gα and Gβ) in host plants to disrupt cellular signaling [2, 14]; inhibits nitric oxide (NO) production in mammalian macrophages [12].

03

Biological functions

PhytotoxicitySeed germination inhibitionImmune suppressionAnti-inflammatory activityNitric oxide inhibition
04

Disease associations

Infection (Plant)Inflammation
05

Safety considerations

Phytotoxicity

Beyond the preview

Go deeper on Sorokinianin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorokinianin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call